Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Combination Therapy: While low-risk on their own, GLP-1 RAs increase hypoglycemia risk when combined with insulin or sulfonylureas
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes. Lancet
Interaction with Certain Medications The supplements may interact with certain medications, including blood thinners and thyroid hormone replacement therapy
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Castenmiller, J., de Henauw, S., Hirsch-Ernst, K
Even pregnant or nursing women must avoid it, as there is no safety data for this group
US$ 21.36
US$ 29.73
US$ 25.33
US$ 25.62
